BridgeBio Pharma, Inc.
BridgeBio Pharma develops medicines for genetic conditions across multiple therapeutic programs using its hub-and-spoke organizational model.
SCHEDULE 13G/ANov 12Latest SEC filing
Nov 9Latest story
October 2026
August 2026
July 2026